About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 898719, 7 pages
http://dx.doi.org/10.1155/2013/898719
Research Article

Impact of the 2009 (7th Edition) AJCC Melanoma Staging System in the Classification of Thin Cutaneous Melanomas

1Department of Pathology, Baylor College of Medicine, Houston, TX 77030, USA
2Section of Dermatopathology, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
3Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
4Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

Received 30 September 2013; Revised 23 October 2013; Accepted 28 October 2013

Academic Editor: Giuseppe Argenziano

Copyright © 2013 Vicki H. Chu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. S. Rigel, “Epidemiology of melanoma,” Seminars in Cutaneous Medicine and Surgery, vol. 29, no. 4, pp. 204–209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M. J. Thun, “Cancer statistics, 2009,” CA: Cancer Journal for Clinicians, vol. 59, no. 4, pp. 225–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. J. E. Frangos, L. M. Duncan, A. Piris et al., “Increased diagnosis of thin superficial spreading melanomas: a 20-year study,” Journal of the American Academy of Dermatology, vol. 67, no. 3, pp. 387–394, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Jemal, M. Saraiya, P. Patel et al., “Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992–2006,” Journal of the American Academy of Dermatology, vol. 65, no. 5, supplement 1, pp. S17.e1–S17.e11, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Breslow, “Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma,” Annals of Surgery, vol. 172, no. 5, pp. 902–908, 1970. View at Scopus
  6. C. M. Balch, A. C. Buzaid, S. J. Soong et al., “Final version of the American joint committee on cancer staging system for cutaneous melanoma,” Journal of Clinical Oncology, vol. 19, no. 16, pp. 3635–3648, 2001. View at Scopus
  7. C. M. Balch, J. E. Gershenwald, S. Soong et al., “Final version of 2009 AJCC melanoma staging and classification,” Journal of Clinical Oncology, vol. 27, no. 36, pp. 6199–6206, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. W. H. Clark Jr., D. E. Elder, D. T. Guerry et al., “Model predicting survival in stage I melanoma based on tumor progression,” Journal of the National Cancer Institute, vol. 81, no. 24, pp. 1893–1904, 1989. View at Scopus
  9. W. H. Clark Jr., L. From, E. A. Bernardino, and M. C. Mihm, “The histogenesis and biologic behavior of primary human malignant melanomas of the skin,” Cancer Research, vol. 29, no. 3, pp. 705–727, 1969. View at Scopus
  10. A. Breslow, “Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma,” Annals of Surgery, vol. 182, no. 5, pp. 572–575, 1975. View at Scopus
  11. A. C. Halpern and A. A. Marghoob, “Thin melanoma: still “excellent prognosis” disease?” Journal of Clinical Oncology, vol. 22, no. 18, pp. 3651–3653, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. D. E. Elder, “Thin melanoma,” Archives of Pathology and Laboratory Medicine, vol. 135, no. 3, pp. 342–346, 2011.
  13. J. F. Thompson, S. Soong, C. M. Balch et al., “Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American joint committee on cancer melanoma staging database,” Journal of Clinical Oncology, vol. 29, no. 16, pp. 2199–2205, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. C. M. Balch, J. E. Gershenwald, S. Soong, and J. F. Thompson, “Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate,” Journal of Surgical Oncology, vol. 104, no. 4, pp. 379–385, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. F. Azzola, H. M. Shaw, J. F. Thompson et al., “Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center,” Cancer, vol. 97, no. 6, pp. 1488–1498, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. A. B. Francken, H. M. Shaw, J. F. Thompson et al., “The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up,” Annals of Surgical Oncology, vol. 11, no. 4, pp. 426–433, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. P. A. Gimotty and D. Guerry, “Prognostication in thin cutaneous melanomas,” Archives of Pathology and Laboratory Medicine, vol. 134, no. 12, pp. 1758–1763, 2010. View at Scopus
  18. J. E. Gershenwald, W. Thompson, P. F. Mansfield et al., “Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients,” Journal of Clinical Oncology, vol. 17, no. 3, pp. 976–983, 1999. View at Scopus
  19. G. M. Boland and J. E. Gershenwald, “Sentinel lymph node biopsy in melanoma,” Cancer Journal, vol. 18, no. 2, pp. 185–191, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. J. E. Gershenwald and M. I. Ross, “Sentinel-lymph-node biopsy for cutaneous melanoma,” The New England Journal of Medicine, vol. 364, no. 18, pp. 1738–1745, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. D. L. Morton, D. R. Wen, J. H. Wong et al., “Technical details of intraoperative lymphatic mapping for early stage melanoma,” Archives of Surgery, vol. 127, no. 4, pp. 392–399, 1992. View at Scopus
  22. R. H. I. Andtbacka and J. E. Gershenwald, “Role of sentinel lymph node biopsy in patients with thin melanoma,” Journal of the National Comprehensive Cancer Network, vol. 7, no. 3, pp. 308–317, 2009. View at Scopus
  23. C. Schmoeckel and O. Braun-Falco, “Prognostic index in malignant melanoma,” Archives of Dermatology, vol. 114, no. 6, pp. 871–873, 1978. View at Publisher · View at Google Scholar · View at Scopus
  24. V. J. McGovern, A. J. Cochran, and E. P. van der Esch, “The classification of malignant melanoma, its histological reporting and registration: a revision of the 1972 Sydney classification,” Pathology, vol. 18, no. 1, pp. 12–21, 1986. View at Scopus
  25. V. G. Prieto, “Sentinel lymph nodes in cutaneous melanoma: handling, examination, and clinical repercussion,” Archives of Pathology and Laboratory Medicine, vol. 134, no. 12, pp. 1764–1769, 2010. View at Scopus
  26. V. G. Prieto and S. H. Clark, “Processing of sentinel lymph nodes for detection of metastatic melanoma,” Annals of Diagnostic Pathology, vol. 6, no. 4, pp. 257–264, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. V. G. Prieto, Sentinel Lymph Node Biopsy in Melanoma Pathology, edited by J. A. Reed, Medscape, 2011.
  28. S. A. Sekula-Gibbs and M. A. Shearer, “Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one,” Dermatologic Surgery, vol. 37, no. 8, pp. 1080–1088, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Piris, M. C. Mihm Jr., and L. M. Duncan, “AJCC melanoma staging update: impact on dermatopathology practice and patient management,” Journal of Cutaneous Pathology, vol. 38, no. 5, pp. 394–400, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. P. V. Dickson and J. E. Gershenwald, “Staging and prognosis of cutaneous melanoma,” Surgical Oncology Clinics of North America, vol. 20, no. 1, pp. 1–17, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. J. E. Gershenwald, D. G. Coit, V. K. Sondak, and J. F. Thompson, “The challenge of defining guidelines for sentinel lymph node biopsy in patients with thin primary cutaneous melanomas,” Annals of Surgical Oncology, vol. 19, no. 11, pp. 3301–3303, 2012. View at Publisher · View at Google Scholar
  32. M. I. Ross and J. E. Gershenwald, “Evidence-based treatment of early-stage melanoma,” Journal of Surgical Oncology, vol. 104, no. 4, pp. 341–353, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. D. V. Yonick, R. M. Ballo, E. Kahn et al., “Predictors of positive sentinel lymph node in thin melanoma,” The American Journal of Surgery, vol. 201, no. 3, pp. 324–328, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Murali, L. E. Haydu, M. J. Quinn et al., “Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma,” Annals of Surgery, vol. 255, no. 1, pp. 128–133, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Testori, G. L. de Salvo, M. C. Montesco et al., “Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI),” Annals of Surgical Oncology, vol. 16, no. 7, pp. 2018–2027, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. K. T. Morris, K. J. Busam, S. Bero, A. Patel, and M. S. Brady, “Primary cutaneous melanoma with regression does not require a lower threshold for sentinel lymph node biopsy,” Annals of Surgical Oncology, vol. 15, no. 1, pp. 316–322, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. S. E. McClain, A. L. Shada, M. Barry, J. W. Patterson, and C. L. Slingluff Jr., “Outcome of sentinel lymph node biopsy and prognostic implications of regression in thin malignant melanoma,” Melanoma Research, vol. 22, no. 4, pp. 302–309, 2012. View at Publisher · View at Google Scholar
  38. A. L. Burton, J. Gilbert, R. W. Farmer et al., “Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma,” The American Surgeon, vol. 77, no. 8, pp. 1009–1013, 2011. View at Scopus
  39. J. Oláh, R. Gyulai, I. Korom, E. Varga, and A. Dobozy, “Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas,” The British Journal of Dermatology, vol. 149, no. 3, pp. 662–663, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Guitart, L. Lowe, M. Piepkorn et al., “Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases,” Archives of Dermatology, vol. 138, no. 5, pp. 603–608, 2002. View at Scopus
  41. B. E. Wright, R. P. Scheri, X. Ye et al., “Importance of sentinel lymph node biopsy in patients with thin melanoma,” Archives of Surgery, vol. 143, no. 9, pp. 892–899, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. M. A. Nading, C. M. Balch, and A. J. Sober, “Implications of the 2009 American joint committee on cancer melanoma staging and classification on dermatologists and their patients,” Seminars in Cutaneous Medicine and Surgery, vol. 29, no. 3, pp. 142–147, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Murali, L. E. Haydu, G. V. Long et al., “Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma,” Annals of Surgical Oncology, vol. 19, no. 6, pp. 1782–1789, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. V. P. Koshenkov, D. Shulkin, R. Bustami, A. H. Chevinsky, and E. D. Whitman, “Role of sentinel lymphadenectomy in thin cutaneous melanomas with positive deep margins on initial biopsy,” Journal of Surgical Oncology, vol. 106, no. 4, pp. 363–368, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. J. G. McKinnon, X. Q. Yu, W. H. McCarthy, and J. F. Thompson, “Prognosis for patients with thin cutaneous melanoma: long-term survival data from the New South Wales central cancer registry and the Sydney melanoma unit,” Cancer, vol. 98, no. 6, pp. 1223–1231, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. J. M. Ranieri, J. D. Wagner, S. Wenck, C. S. Johnson, and J. J. Coleman III, “The prognostic importance of sentinel lymph node biopsy in thin melanoma,” Annals of Surgical Oncology, vol. 13, no. 7, pp. 927–932, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. M. B. Faries, L. A. Wanek, D. Elashoff, B. E. Wright, and D. L. Morton, “Predictors of occult nodal metastasis in patients with thin melanoma,” Archives of Surgery, vol. 145, no. 2, pp. 137–142, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. C. A. Puleo, J. L. Messina, A. I. Riker et al., “Sentinel node biopsy for thin melanomas: which patients should be considered?” Cancer Control, vol. 12, no. 4, pp. 230–235, 2005. View at Scopus
  49. D. Han, D. Yu, X. Zhao, et al., “Sentinel node biopsy is indicated for thin melanomas ≥0.76 mm,” Annals of Surgical Oncology, vol. 19, no. 11, pp. 3335–3342, 2012. View at Publisher · View at Google Scholar
  50. A. S. Caudle, M. I. Ross, V. G. Prieto et al., “Mitotic rate predicts sentinel lymph node involvement in melanoma: impact of the 7th edition AJCC melanoma staging system,” Annals of Surgical Oncology, vol. 17, no. 8, 2010.
  51. R. Murali, R. A. Scolyer, and J. F. Thompson, “Can we better identify thin cutaneous melanomas that are likely to metastasize and cause death?” Annals of Surgical Oncology, vol. 19, no. 11, pp. 3310–3312, 2012. View at Publisher · View at Google Scholar
  52. D. Ivan and V. G. Prieto, “An update on reporting histopathologic prognostic factors in melanoma,” Archives of Pathology and Laboratory Medicine, vol. 135, no. 7, pp. 825–829, 2011. View at Scopus